clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT04599478 |
P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
phase II clinical trial | Q42824440 | ||
P582 | end time | 2026-01-01 | |
P4135 | maximum age | 70 | |
P1050 | medical condition | overweight | Q332428 |
P2899 | minimum age | 18 | |
P1132 | number of participants | 160 | |
P4844 | research intervention | naltrexone | Q409587 |
bupropion | Q834280 | ||
P8005 | research subject recruitment status | not yet recruiting | Q76649614 |
P580 | start time | 2021-02-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Acute (Stage 1) |
Search more.